Mühlstädt M |
Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient. |
2016 |
Dermatology (Basel) |
pmid:27513345
|
Gaide O and Cattin V |
Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis. |
2016 |
Dermatology (Basel) |
pmid:27513756
|
Tzika E et al. |
Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis. |
2016 |
Dermatology (Basel) |
pmid:27513668
|
Stieger M and Hunger RE |
Ingenol Mebutate Treatment in a Patient with Gorlin Syndrome. |
2016 |
Dermatology (Basel) |
pmid:27513585
|
Gadaldi K et al. |
Ingenol Mebutate for Lentigo Maligna: A Case Report. |
2016 |
Dermatology (Basel) |
pmid:27513527
|
Alkhalaf A and Hofbauer GF |
Ingenol Mebutate 150 mg as Physician-Directed Treatment of Bowen's Disease Under Occlusion. |
2016 |
Dermatology (Basel) |
pmid:27512986
|
Le TT et al. |
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate. |
2016 |
PLoS ONE |
pmid:27100888
|
Bhandari PR and Pai VV |
Could ingenol mebutate be useful in managing nonmelanoma skin cancers? |
2015 Apr-Jun |
Indian J Cancer |
pmid:26853424
|
Freiberger SN et al. |
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2. |
2015 |
Mol. Cancer Ther. |
pmid:26116359
|
Soini EJ et al. |
Cost-utility of first-line actinic keratosis treatments in Finland. |
2015 |
Adv Ther |
pmid:26006101
|